Literature DB >> 32349125

Prediction of drug adverse events using deep learning in pharmaceutical discovery.

Chun Yen Lee1, Yi-Ping Phoebe Chen1.   

Abstract

Traditional machine learning methods used to detect the side effects of drugs pose significant challenges as feature engineering processes are labor-intensive, expert-dependent, time-consuming and cost-ineffective. Moreover, these methods only focus on detecting the association between drugs and their side effects or classifying drug-drug interaction. Motivated by technological advancements and the availability of big data, we provide a review on the detection and classification of side effects using deep learning approaches. It is shown that the effective integration of heterogeneous, multidimensional drug data sources, together with the innovative deployment of deep learning approaches, helps reduce or prevent the occurrence of adverse drug reactions (ADRs). Deep learning approaches can also be exploited to find replacements for drugs which have side effects or help to diversify the utilization of drugs through drug repurposing.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Keywords:  adverse drug reactions; deep learning; pharmacovigilance

Year:  2021        PMID: 32349125     DOI: 10.1093/bib/bbaa040

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  8 in total

Review 1.  Drug targets for COVID-19 therapeutics: Ongoing global efforts.

Authors:  Ambrish Saxena
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

2.  Adverse Drug Reaction Discovery Using a Tumor-Biomarker Knowledge Graph.

Authors:  Meng Wang; Xinyu Ma; Jingwen Si; Hongjia Tang; Haofen Wang; Tunliang Li; Wen Ouyang; Liying Gong; Yongzhong Tang; Xi He; Wei Huang; Xing Liu
Journal:  Front Genet       Date:  2021-01-12       Impact factor: 4.599

3.  Predictive Analytics for Care and Management of Patients With Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes.

Authors:  Jessica Qiuhua Sheng; Paul Jen-Hwa Hu; Xiao Liu; Ting-Shuo Huang; Yu Hsien Chen
Journal:  J Med Internet Res       Date:  2021-02-12       Impact factor: 5.428

4.  A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms.

Authors:  Adeeb Noor
Journal:  J Healthc Eng       Date:  2022-03-03       Impact factor: 2.682

5.  PregTox: A Resource of Knowledge about Drug Fetal Toxicity.

Authors:  Qingqing Chen; Yu Gan; Kejian Wang; Qing Li
Journal:  Biomed Res Int       Date:  2022-04-16       Impact factor: 3.246

Review 6.  Recent Progress in Traditional Chinese Medicines and Their Mechanism in the Treatment of Allergic Rhinitis.

Authors:  Dehong Mao; Zhongmei He; Linglong Li; Yuting Lei; Maodi Xiao; Huimin Zhang; Feng Zhang
Journal:  J Healthc Eng       Date:  2022-04-11       Impact factor: 3.822

Review 7.  Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports.

Authors:  Theodoros G Soldatos; Sarah Kim; Stephan Schmidt; Lawrence J Lesko; David B Jackson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-02-20

Review 8.  Drug repositioning: A bibliometric analysis.

Authors:  Guojun Sun; Dashun Dong; Zuojun Dong; Qian Zhang; Hui Fang; Chaojun Wang; Shaoya Zhang; Shuaijun Wu; Yichen Dong; Yuehua Wan
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.